As an enterprise group with a certain influence in domestic biopharmaceutical field, CCHT has been assiduously pursuing in product research, production guarantee, marketing management and other aspects and has been continuously exploring and enhancing its enterprise value and connotation.
After years of accumulation, CCHT has been increasingly improved in biopharmaceutical, new product research and development, characteristic real estate, industrial investment and other aspects, and its core competitiveness has been continuously strengthened, adhereing to investment holding, strategic management and control management mode. Implementing the industrial strategy with biopharmaceutical industry as the primary and real estate industry as the supplement, CCHT encourages the personalized development of enterprise while pursuing the overall coordination and profit maximization.
The pharmaceutical products cover innovative genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicine and other pharmaceutical market segments, shaping a good brand image and gradually winning market recognition. In the aspect of the layout of pharmaceutical industry, CCHT insists on the market orientation. On the one hand, on the basis of the existing product process facilities, the product innovation ability is constantly strengthened by utilizing its own technology and R&D advantages. On the other hand, through the successful incubation and industrial cultivation of innovative projects, the product structure with certain technological and market advantages in the fields of genetic engineering pharmacy, biological vaccine and modern traditional Chinese medicine is created and formed.